Terms: = Prostate cancer AND CEACAM5, CEA AND Staging
8 results:
1. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
Moe K; Maa HC; Pei D; Liang YJ; Chen YL
Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
[TBL] [Abstract] [Full Text] [Related]
3. [The carcinoembryonic antigen: apropos of an old friend].
Téllez-Avila FI; García-Osogobio SM
Rev Invest Clin; 2005; 57(6):814-9. PubMed ID: 16708907
[TBL] [Abstract] [Full Text] [Related]
4. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract] [Full Text] [Related]
5. Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction.
Jung R; Ahmad-Nejad P; Wimmer M; Gerhard M; Wagener C; Neumaier M
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):3-10. PubMed ID: 9156564
[TBL] [Abstract] [Full Text] [Related]
6. Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Tarle M; Radoś N
Prostate; 1991; 19(1):23-33. PubMed ID: 1715080
[TBL] [Abstract] [Full Text] [Related]
7. [Radioimmunoassays in oncology].
Dressler J
Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
[TBL] [Abstract] [Full Text] [Related]
8. [Laboratory tools in the diagnosis of prostatic cancer (author's transl)].
Jacobi GH
Urologe A; 1979 Nov; 18(6):311-5. PubMed ID: 388799
[TBL] [Abstract] [Full Text] [Related]
